Dimensional Fund Advisors’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-988
| Closed | -$32K | – | 3552 |
|
|
2022
Q1 | $32K | Sell |
988
-1,237
| -56% | -$48.6K | ﹤0.01% | 3486 |
|
|
2021
Q4 | $106K | Buy |
2,225
+132
| +6% | +$9.1K | ﹤0.01% | 3434 |
|
|
2021
Q3 | $193K | Sell |
2,093
-1,777
| -46% | -$147K | ﹤0.01% | 3354 |
|
|
2021
Q2 | $369K | Buy |
3,870
+1,227
| +46% | +$107K | ﹤0.01% | 3220 |
|
|
2021
Q1 | $257K | Buy |
+2,643
| New | +$325K | ﹤0.01% | 3246 |
|
|
2020
Q4 | – | Sell |
-3,595
| Closed | -$222K | – | 3369 |
|
|
2020
Q3 | $222K | Sell |
3,595
-12,263
| -77% | -$925K | ﹤0.01% | 3191 |
|
|
2020
Q2 | $1.4M | Sell |
15,858
-7,352
| -32% | -$777K | ﹤0.01% | 2849 |
|
|
2020
Q1 | $2.6M | Sell |
23,210
-1,669
| -7% | -$329K | ﹤0.01% | 2623 |
|
|
2019
Q4 | $6.09M | Sell |
24,879
-1,380
| -5% | -$348K | ﹤0.01% | 2543 |
|
|
2019
Q3 | $9.04M | Sell |
26,259
-1,971
| -7% | -$1.07M | ﹤0.01% | 2380 |
|
|
2019
Q2 | $26M | Buy |
28,230
+2,078
| +8% | +$2.55M | 0.01% | 1904 |
|
|
2019
Q1 | $41.7M | Buy |
26,152
+1,960
| +8% | +$3.53M | 0.02% | 1587 |
|
|
2018
Q4 | $45.2M | Buy |
24,192
+88
| +0.4% | +$191K | 0.02% | 1373 |
|
|
2018
Q3 | $56.8M | Sell |
24,104
-610
| -2% | -$1.89M | 0.02% | 1327 |
|
|
2018
Q2 | $85.1M | Sell |
24,714
-1,301
| -5% | -$3.98M | 0.03% | 805 |
|
|
2018
Q1 | $73.8M | Buy |
26,015
+1,393
| +6% | +$4.17M | 0.03% | 901 |
|
|
2017
Q4 | $63.4M | Buy |
24,622
+2,489
| +11% | +$7.08M | 0.03% | 1079 |
|
|
2017
Q3 | $62.8M | Buy |
22,133
+2,359
| +12% | +$6.21M | 0.03% | 1035 |
|
|
2017
Q2 | $46.7M | Buy |
19,774
+4,512
| +30% | +$8.94M | 0.02% | 1316 |
|
|
2017
Q1 | $38.5M | Buy |
15,262
+2,699
| +21% | +$7.77M | 0.02% | 1474 |
|
|
2016
Q4 | $28.3M | Buy |
12,563
+1,365
| +12% | +$3.25M | 0.01% | 1699 |
|
|
2016
Q3 | $28.1M | Sell |
11,198
-23
| -0.2% | -$68.6K | 0.02% | 1636 |
|
|
2016
Q2 | $34.3M | Buy |
11,221
+1,447
| +15% | +$4.71M | 0.02% | 1365 |
|
|
2016
Q1 | $31M | Buy |
9,774
+631
| +7% | +$2.62M | 0.02% | 1430 |
|
|
2015
Q4 | $46.9M | Buy |
9,143
+183
| +2% | +$800K | 0.03% | 909 |
|
|
2015
Q3 | $28.5M | Buy |
8,960
+207
| +2% | +$803K | 0.02% | 1400 |
|
|
2015
Q2 | $35M | Buy |
8,753
+946
| +12% | +$3.65M | 0.02% | 1262 |
|
|
2015
Q1 | $31.2M | Buy |
7,807
+2,304
| +42% | +$10.6M | 0.02% | 1344 |
|
|
2014
Q4 | $27M | Sell |
5,503
-23
| -0.4% | -$98.7K | 0.02% | 1421 |
|
|
2014
Q3 | $22.5M | Sell |
5,526
-66
| -1% | -$248K | 0.02% | 1505 |
|
|
2014
Q2 | $22.6M | Sell |
5,592
-14
| -0.2% | -$57.1K | 0.02% | 1536 |
|
|
2014
Q1 | $25.5M | Sell |
5,606
-54
| -1% | -$218K | 0.02% | 1315 |
|
|
2013
Q4 | $19.8M | Buy |
5,660
+18
| +0.3% | +$70.2K | 0.02% | 1565 |
|
|
2013
Q3 | $23.2M | Buy |
5,642
+343
| +6% | +$1.48M | 0.02% | 1244 |
|
|
2013
Q2 | $21M | Buy |
+5,299
| New | +$21.8M | 0.02% | 1227 |
|
Other funds holding ACOR
DKCM
CCA
VF
SC
BCM
Dimensional Fund Advisors's ACOR Position: Q2 2022 in Review
Dimensional Fund Advisors sold out of Acorda Therapeutics (ACOR) in Q2 2022, closing a stake of 988 shares — an estimated $32K sold.
Dimensional Fund Advisors first reported a position in ACOR in Q2 2013 and held it in 35 quarters. The position peaked at $85.1M in Q2 2018. 32 funds tracked by Wall St. Rank hold ACOR as of Q2 2022.
- Dimensional Fund Advisors reported no remaining Acorda Therapeutics position as of Q2 2022 after selling out during the quarter.
- Dimensional Fund Advisors sold 988 Acorda Therapeutics shares in Q2 2022, an estimated $32K.
- Dimensional Fund Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 35 quarters.
- Dimensional Fund Advisors's Acorda Therapeutics position peaked at $85.1M in Q2 2018.
- 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2022.
Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.